Clues to the etiology of bile duct injury in Biliary atresia

Seminars in Liver Disease

Volumn 32, Issue 4, 2012, Pages 307-316

  MacK, Cara L ^a   Feldman, Amy G ^a   Sokol, Ronald J ^a  

^a Children's Hospital Colorado   (United States)

Author keywords

adaptive immunity; humoral immunity; innate immunity; neonatal cholestasis

Indexed keywords

ADDUCIN 3; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE; PEPTIDE HYDROLASE; TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; X PROLYL AMINOPEPTIDASE P1;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BILE DUCT ATRESIA; BILE DUCT INJURY; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; MACROPHAGE; MORPHOGENESIS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REOVIRUS; ROTAVIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL; VASCULAR DISEASE; VIRUS INFECTION;

AUTOIMMUNITY; BILIARY ATRESIA; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; VIRUS DISEASES;

EID: 84873364829     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0032-1329899     Document Type: Article

References (119)

1. Mack C. L., Sokol R. J. Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res: 2005; 57 5 Pt 2 87R 94R (Pubitemid 40593251)
2. Sokol R. J., Mack C., Narkewicz M. R., Karrer F. M. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr: 2003; 37 1 4 21 (Pubitemid 39274562)
3. Hartley J. L., Davenport M., Kelly D. A. Biliary atresia. Lancet: 2009; 374 9702 1704 1713
4. Petersen C. Pathogenesis and treatment opportunities for biliary atresia. Clin Liver Dis: 2006; 10 1 73 88, vi vi (Pubitemid 41821378)
5. Bessho K., Bezerra J. A. Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med: 2011; 62 171 185
6. Lien T. H., Chang M. H., Wu J. F., et al. Taiwan Infant Stool Color Card Study Group Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology: 2011; 53 1 202 208
7. Desmet V. J. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformationo" Hepatology: 1992; 16 4 1069 1083
8. Tan C. E., Driver M., Howard E. R., Moscoso G. J. Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg: 1994; 29 6 808 814 (Pubitemid 24191371)
9. Riepenhoff-Talty M., Gouvea V., Evans M. J., et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis: 1996; 174 1 8 15 (Pubitemid 26255549)
10. Morecki R., Glaser J. H., Cho S., Balistreri W. F., Horwitz M. S. Biliary atresia and reovirus type 3 infection. N Engl J Med: 1982; 307 8 481 484 (Pubitemid 12095137)
11. Jevon G. P., Dimmick J. E. Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol: 1999; 2 1 11 14 (Pubitemid 29173003)
12. Sokol R. J., Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis: 2001; 21 4 517 524 (Pubitemid 33131043)
13. Mack C. L. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis: 2007; 27 3 233 242
14. Harpavat S., Finegold M. J., Karpen S. J. Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics: 2011; 128 6 e1428 e1433
15. Landing B. H. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst-the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg: 1974; 6 113 139
16. al-Masri A. N., Werfel T., Jakschies D., von Wussow P. Intracellular staining of Mx proteins in cells from peripheral blood, bone marrow and skin. Mol Pathol: 1997; 50 1 9 14
17. Huang Y. H., Chou M. H., Du Y. Y., et al. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest: 2007; 87 1 66 74
18. Rauschenfels S., Krassmann M., Al-Masri A. N., et al. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr: 2009; 168 4 469 476
19. Domiati-Saad R., Dawson D. B., Margraf L. R., Finegold M. J., Weinberg A. G., Rogers B. B. Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr Dev Pathol: 2000; 3 4 367 373 (Pubitemid 30421951)
20. Drut R., Drut R. M., Gómez M. A., Cueto Rúa E., Lojo M. M. Presence of human papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr: 1998; 27 5 530 535 (Pubitemid 28492252)
21. Mahjoub F., Shahsiah R., Ardalan F. A., et al. Detection of Epstein Barr virus by chromogenic in situ hybridization in cases of extra-hepatic biliary atresia. Diagn Pathol: 2008; 3 19
22. Fischler B., Ehrnst A., Forsgren M., Orvell C., Nemeth A. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr: 1998; 27 1 57 64 (Pubitemid 28293026)
23. Tyler K. L., Sokol R. J., Oberhaus S. M., et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology: 1998; 27 6 1475 1482 (Pubitemid 28264668)
24. Stanley N. F., Dorman D. C., Ponsford J. Studies on the pathogenesis of a hitherto undescribed virus (hepato-encephalomyelitis) producing unusual symptoms in suckling mice. Aust J Exp Biol Med Sci: 1953; 31 2 147 159
25. Papadimitriou J. M. The biliary tract in acute murine reovirus 3 infection. Light and electron microscopic study. Am J Pathol: 1968; 52 3 595 611
26. Bangaru B., Morecki R., Glaser J. H., Gartner L. M., Horwitz M. S. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest: 1980; 43 5 456 462 (Pubitemid 11241613)
27. Phillips P. A., Keast D., Papadimitriou J. M., Walters M. N., Stanley N. F. Chronic obstructive jaundice induced by reovirus type 3 in weanling mice. Pathology: 1969; 1 3 193 203
28. Wilson G. A., Morrison L. A., Fields B. N. Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice. J Virol: 1994; 68 10 6458 6465 (Pubitemid 24294896)
29. Parashar K., Tarlow M. J., McCrae M. A. Experimental reovirus type 3-induced murine biliary tract disease. J Pediatr Surg: 1992; 27 7 843 847
30. Barton E. S., Youree B. E., Ebert D. H., et al. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest: 2003; 111 12 1823 1833 (Pubitemid 38057727)
31. Harada K., Sato Y., Itatsu K., et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology: 2007; 46 4 1146 1154 (Pubitemid 350144779)
32. Glaser J. H., Balistreri W. F., Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr: 1984; 105 6 912 915 (Pubitemid 15185317)
33. Richardson S. C., Bishop R. F., Smith A. L. Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. J Gastroenterol Hepatol: 1994; 9 3 264 268 (Pubitemid 24149289)
34. Brown W. R., Sokol R. J., Levin M. J., et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr: 1988; 113 4 670 676
35. Dussaix E., Hadchouel M., Tardieu M., Alagille D. Biliary atresia and reovirus type 3 infection. N Engl J Med: 1984; 310 10 658 (Pubitemid 14194388)
36. Steele M. I., Marshall C. M., Lloyd R. E., Randolph V. E. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology: 1995; 21 3 697 702
37. Riepenhoff-Talty M., Schaekel K., Clark H. F., et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res: 1993; 33 4 Pt 1 394 399 (Pubitemid 23095773)
38. Czech-Schmidt G., Verhagen W., Szavay P., Leonhardt J., Petersen C. Immunological gap in the infectious animal model for biliary atresia. J Surg Res: 2001; 101 1 62 67 (Pubitemid 33030108)
39. Mack C. L., Tucker R. M., Sokol R. J., Kotzin B. L. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol: 2005; 115 2 200 209 (Pubitemid 40693091)
40. Allen S. R., Jafri M., Donnelly B., et al. Effect of rotavirus strain on the murine model of biliary atresia. J Virol: 2007; 81 4 1671 1679 (Pubitemid 46214442)
41. Wang W., Donnelly B., Bondoc A., et al. The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice. J Virol: 2011; 85 17 9069 9077
42. Feng N., Sen A., Wolf M., Vo P., Hoshino Y., Greenberg H. B. Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract. J Virol: 2011; 85 6 2686 2694
43. Jafri M., Donnelly B., Allen S., et al. Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol: 2008; 295 1 G16 G26
44. Bobo L., Ojeh C., Chiu D., Machado A., Colombani P., Schwarz K. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res: 1997; 41 2 229 234 (Pubitemid 27066349)
45. Ko H. M., Kim K. S., Park J. W., et al. Congenital cytomegalovirus infection: three autopsy case reports. J Korean Med Sci: 2000; 15 3 337 342
46. Martelius T., Krogerus L., Höckerstedt K., Bruggeman C., Lautenschlager I. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology: 1998; 27 4 996 1002 (Pubitemid 28160485)
47. Evans P. C., Coleman N., Wreghitt T. G., Wight D. G., Alexander G. J. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol: 1999; 31 5 913 920 (Pubitemid 29514226)
48. Chang M. H., Huang H. H., Huang E. S., Kao C. L., Hsu H. Y., Lee C. Y. Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology: 1992; 103 3 1022 1025
49. Potena L., Valantine H. A. Cytomegalovirus-associated allograft rejection in heart transplant patients. Curr Opin Infect Dis: 2007; 20 4 425 431 (Pubitemid 47026242)
50. Dimmick J. E. Intrahepatic bile duct paucity and cytomegalovirus infection. Pediatr Pathol: 1993; 13 6 847 852 (Pubitemid 23343990)
51. Xu Y., Yu J., Zhang R., et al. The perinatal infection of cytomegalovirus is an important etiology for biliary atresia in China. Clin Pediatr (Phila): 2012; 51 2 109 113
52. Jevon G. P., Dimmick J. E. Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol: 1999; 2 1 11 14 (Pubitemid 29173003)
53. Fischler B., Woxenius S., Nemeth A., Papadogiannakis N. Immunoglobulin deposits in liver tissue from infants with biliary atresia and the correlation to cytomegalovirus infection. J Pediatr Surg: 2005; 40 3 541 546 (Pubitemid 40417418)
54. Brindley S. M., Lanham A. M., Karrer F. M., Tucker R. M., Fontenot A. P., Mack C. L. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology: 2012; 55 4 1130 1138
55. Shen C., Zheng S., Wang W., Xiao X. M. Relationship between prognosis of biliary atresia and infection of cytomegalovirus. World J Pediatr: 2008; 4 2 123 126 (Pubitemid 351736698)
56. Fischler B., Svensson J. F., Nemeth A. Early cytomegalovirus infection and the long-term outcome of biliary atresia. Acta Paediatr: 2009; 98 10 1600 1602
57. Serreze D. V., Chapman H. D., Varnum D. S., et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenico" stock of NOD.Ig mu null mice. J Exp Med: 1996; 184 5 2049 2053 (Pubitemid 26404497)
58. Chan O., Shlomchik M. J. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol: 1998; 160 1 51 59 (Pubitemid 28116714)
59. O'Neill S. K., Shlomchik M. J., Glant T. T., Cao Y., Doodes P. D., Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol: 2005; 174 6 3781 3788 (Pubitemid 40354091)
60. Yu S., Maiti P. K., Dyson M., Jain R., Braley-Mullen H. B cell-deficient NOD.H-2h4 mice have CD4 + CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med: 2006; 203 2 349 358 (Pubitemid 43290844)
61. Hadchouel M., Hugon R. N., Odievre M. Immunoglobulin deposits in the biliary remnants of extrahepatic biliary atresia: a study by immunoperoxidase staining in 128 infants. Histopathology: 1981; 5 2 217 221 (Pubitemid 11039336)
62. Mack C. L., Tucker R. M., Lu B. R., et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology: 2006; 44 5 1231 1239 (Pubitemid 44748373)
63. Lu B. R., Brindley S. M., Tucker R. M., Lambert C. L., Mack C. L. α-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology: 2010; 139 5 1753 1761
64. Saulot V., Vittecoq O., Charlionet R., et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum: 2002; 46 5 1196 1201 (Pubitemid 34525825)
65. Vermeulen N., de Béeck K. O., Vermeire S., et al. Identification of a novel autoantigen in inflammatory bowel disease by protein microarray. Inflamm Bowel Dis: 2011; 17 6 1291 1300
66. Forooghian F., Cheung R. K., Smith W. C., O'Connor P., Dosch H. M. Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J Clin Immunol: 2007; 27 4 388 396 (Pubitemid 46906659)
67. Fukuda Y., Miyazawa Y., Imoto M., et al. In situ distribution of enolase isozymes in chronic liver disease. Am J Gastroenterol: 1989; 84 6 601 605 (Pubitemid 19150783)
68. Akisawa N., Maeda T., Iwasaki S., Onishi S. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J Hepatol: 1997; 26 4 845 851 (Pubitemid 27145708)
69. Feldman A., Tucker R., Pelanda R., Mack C. Critical role of B cells in the development of bile duct injury and obstruction in murine biliary atresia. Paper presented at: American Association for the Study of Liver Diseases Annual Meeting; Nov. 4-8, 2011; San Francisco, CA
70. Leonhardt J., Stanulla M., von Wasielewski R., et al. Gene expression profile of the infective murine model for biliary atresia. Pediatr Surg Int: 2006; 22 1 84 89 (Pubitemid 43052204)
71. Carvalho E., Liu C., Shivakumar P., Sabla G., Aronow B., Bezerra J. A. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology: 2005; 129 2 713 717 (Pubitemid 41096655)
72. Shivakumar P., Campbell K. M., Sabla G. E., et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest: 2004; 114 3 322 329 (Pubitemid 39071604)
73. Mohanty S. K., Shivakumar P., Sabla G., Bezerra J. A. Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol: 2006; 6 14
74. Tucker R. M., Hendrickson R. J., Mukaida N., Gill R. G., Mack C. L. Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol: 2007; 20 1 34 43 (Pubitemid 46608950)
75. Li J., Bessho K., Shivakumar P., et al. Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest: 2011; 121 11 4244 4256
76. Davenport M., Gonde C., Redkar R., et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg: 2001; 36 7 1017 1025 (Pubitemid 32619749)
77. Mack C. L., Tucker R. M., Sokol R. J., et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res: 2004; 56 1 79 87 (Pubitemid 38808546)
78. Ahmed A. F., Ohtani H., Nio M., et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J Pathol: 2001; 193 3 383 389 (Pubitemid 32229872)
79. Shinkai M., Shinkai T., Puri P., Stringer M. D. Increased CXCR3 expression associated with CD3-positive lymphocytes in the liver and biliary remnant in biliary atresia. J Pediatr Surg: 2006; 41 5 950 954
80. Ohya T., Fujimoto T., Shimomura H., Miyano T. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg: 1995; 30 4 515 518
81. Bezerra J. A., Tiao G., Ryckman F. C., et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet: 2002; 360 9346 1653 1659 (Pubitemid 35379738)
82. Whitington P. F., Malladi P., Melin-Aldana H., Azzam R., Mack C. L., Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res: 2005; 57 6 837 844 (Pubitemid 40727115)
83. Honsawek S., Vejchapipat P., Chongsrisawat V., Thawornsuk N., Poovorawan Y. Association of circulating osteopontin levels with clinical outcomes in postoperative biliary atresia. Pediatr Surg Int: 2011; 27 3 283 288
84. Narayanaswamy B., Gonde C., Tredger J. M., Hussain M., Vergani D., Davenport M. Serial circulating markers of inflammation in biliary atresia-evolution of the post-operative inflammatory process. Hepatology: 2007; 46 1 180 187 (Pubitemid 47171935)
85. Arikan C., Berdeli A., Kilic M., Tumgor G., Yagci R. V., Aydogdu S. Polymorphisms of the ICAM-1 gene are associated with biliary atresia. Dig Dis Sci: 2008; 53 7 2000 2004
86. Shivakumar P., Sabla G., Mohanty S., et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology: 2007; 133 1 268 277 (Pubitemid 47031130)
87. Rose N. R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today: 1993; 14 9 426 430 (Pubitemid 23271739)
88. Mack C. L., Falta M. T., Sullivan A. K., et al. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology: 2007; 133 1 278 287 (Pubitemid 47031131)
89. Broomé U., Nemeth A., Hultcrantz R., Scheynius A. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol: 1997; 26 4 857 862 (Pubitemid 27145710)
90. Feng J., Li M., Gu W., Tang H., Yu S. The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study. J Pediatr Surg: 2004; 39 11 1658 1662 (Pubitemid 39487995)
91. Donaldson P. T., Clare M., Constantini P. K., et al. HLA and cytokine gene polymorphisms in biliary atresia. Liver: 2002; 22 3 213 219 (Pubitemid 34846359)
92. Yuasa T., Tsuji H., Kimura S., et al. Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation. Hum Immunol: 2005; 66 3 295 300 (Pubitemid 40395250)
93. Davenport M., Stringer M. D., Tizzard S. A., McClean P., Mieli-Vergani G., Hadzic N. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology: 2007; 46 6 1821 1827
94. Petersen C., Harder D., Melter M., et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol: 2008; 103 3 712 719 (Pubitemid 351406001)
95. Sarkhy A., Schreiber R. A., Milner R. A., Barker C. C. Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis. Can J Gastroenterol: 2011; 25 8 440 444
96. Sokol R. J. New North American research network focuses on biliary atresia and neonatal liver disease. J Pediatr Gastroenterol Nutr: 2003; 36 1 1 (Pubitemid 41672609)
97. Grindebacke H., Stenstad H., Quiding-Järbrink M., et al. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4 + CD25 high regulatory T cells. J Immunol: 2009; 183 7 4360 4370
98. Miethke A. G., Saxena V., Shivakumar P., Sabla G. E., Simmons J., Chougnet C. A. Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia. J Hepatol: 2010; 52 5 718 726
99. Lages C. S., Simmons J., Chougnet C. A., Miethke A. G. Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia. Hepatology: 2012; 56 1 219 227
100. Krüger D. H., Schroeder C., Santibanez-Koref M., Reuter M. Avoidance of DNA methylation. A virus-encoded methylase inhibitor and evidence for counterselection of methylase recognition sites in viral genomes. Cell Biophys: 1989; 15 1-2 87 95 (Pubitemid 19211816)
101. Ogasawara H., Okada M., Kaneko H., Hishikawa T., Sekigawa I., Hashimoto H. Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin Exp Rheumatol: 2003; 21 6 733 738 (Pubitemid 38008756)
102. Lee P. P., Fitzpatrick D. R., Beard C., et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity: 2001; 15 5 763 774 (Pubitemid 34008504)
103. Zhang D. Y., Sabla G., Shivakumar P., et al. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology: 2004; 39 4 954 962 (Pubitemid 38428934)
104. Matthews R. P., Eauclaire S. F., Mugnier M., et al. DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia. Hepatology: 2011; 53 3 905 914
105. Dong R., Zhao R., Zheng S. Changes in epigenetic regulation of CD4+ T lymphocytesin biliary atresia. Pediatr Res: 2011; 70 6 555 559
106. Garcia-Barceló M. M., Yeung M. Y., Miao X. P., et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet: 2010; 19 14 2917 2925
107. Lane T., Lachmann H. J. The emerging role of interleukin-1β in autoinflammatory diseases. Curr Allergy Asthma Rep: 2011; 11 5 361 368
108. Harada K., Nakanuma Y. Cholangiopathy with respect to biliary innate immunity. Int J Hepatol: 2012; 2012 793569 793569
109. Chuang J. H., Chou M. H., Wu C. L., Du Y. Y. Implication of innate immunity in the pathogenesis of biliary atresia. Chang Gung Med J: 2006; 29 3 240 250
110. Lövgren T., Eloranta M. L., Båve U., Alm G. V., Rönnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum: 2004; 50 6 1861 1872 (Pubitemid 38725099)
111. Saito T., Hishiki T., Terui K., et al. Toll-like receptor mRNA expression in liver tissue from patients with biliary atresia. J Pediatr Gastroenterol Nutr: 2011; 53 6 620 626
112. Tracy T. F. Jr, Dillon P., Fox E. S., Minnick K., Vogler C. The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J Pediatr Surg: 1996; 31 1 121 125, discussion 125-126
113. Urushihara N., Iwagaki H., Yagi T., et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg: 2000; 35 3 446 449 (Pubitemid 30131608)
114. Kobayashi H., Puri P., O'Briain D. S., Surana R., Miyano T. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg: 1997; 32 4 590 593 (Pubitemid 27175770)
115. Shih H. H., Lin T. M., Chuang J. H., et al. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis. Pediatrics: 2005; 116 2 437 441
116. Arikan C., Berdeli A., Ozgenc F., Tumgor G., Yagci R. V., Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia. J Pediatr Gastroenterol Nutr: 2006; 42 1 77 82 (Pubitemid 43061014)
117. Donn R., Alourfi Z., Zeggini E., et al. British Paediatric Rheumatology Study Group A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum: 2004; 50 5 1604 1610 (Pubitemid 38608083)
118. Nohara H., Okayama N., Inoue N., et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol: 2004; 39 3 242 246 (Pubitemid 38519429)
119. Glaser S. S. Biliary atresia: is lack of innate immune response tolerance key to pathogenesis? Liver Int: 2008; 28 5 587 588 (Pubitemid 351541088)